Device Trial Radar · NCT06531876
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
Last checked: Nov 20, 2026Latest source record: Mar 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
78
Actual
Start
Jul 1, 2024
Primary completion
Feb 27, 2026
Study completion Mar 1, 2026
Sponsor
- Lead sponsor
- Beacon BiosignalsNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Kaiser Permanente; Stanford University; Intrepid Research; Sleep Insights; Sleep Management Institute
- First posted
- Aug 1, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study intends to examine the utility of a home-use EEG-based sleep monitor for the diagnosis and evaluation of disorders of excessive sleepiness, specifically the neurological disorder Narcolepsy Type 1.
Conditions
- Narcolepsy Type 1
- Hypersomnia
- Sleep Disorder
Interventions
Dreem 3S recordingDevice
Subjects in both Arms A and B will undergo at-home recording with the Dreem 3S EEG Headband to assess sleep. Subjects will undergo in-lab polysomnography and multiple sleep latency testing while also wearing the Dreem 3S EEG headband system. Arm B participants will be asked to withdraw from some or all of their Narcolepsy related medication therapy for roughly 19 days in order to assess the ability of the Dreem Headband System in characterizing sleep disturbances related to Narcolepsy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compliance with Dreem 3STime frame: 1 week
- Consensus sleep stagingTime frame: Days 9-10 (est)
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Kaiser Permanente Fontana Medical Center
Fontana, California
Stanford University
Redwood City, California
Sleep Insights Medical Associates PLLC
Rochester, New York
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.